In Vitro and In Silico Alternatives to Animal Testing

A range of non-animal testing technologies are advancing rapidly, offering the prospect of more predictive science with reduced animal welfare burden across multiple research domains.

Key Facts

Microphysiological systems (organ-on-chip) replicate human tissue function with higher human predictive validity than animal models for some applications
3D bioprinted human skin models have replaced rabbit Draize tests for eye and skin irritation in cosmetics
Computer models using QSAR analysis predict drug toxicity without animal testing in some early discovery applications
Human iPSC-derived organoids (miniature human organs from stem cells) are replacing animal models in some disease research
The EU has committed to developing a roadmap for phase-out of regulatory animal testing through alternative methods

Welfare Considerations

The development of non-animal testing alternatives is advancing at an accelerating pace, driven by both ethical pressure and the recognition that many animal models fail to predict human outcomes adequately. Each validated alternative method that replaces an animal test prevents the suffering of potentially thousands of animals per year of use. The challenge is the validation and regulatory acceptance process — new methods must be proven equivalent to existing animal tests before they can replace them, a process that takes years. Investment in faster validation pathways, combined with regulatory pressure to accept validated alternatives, would accelerate the transition. This is an area where both scientific and welfare progress are aligned.

What You Can Do

Support NC3Rs investment in developing and validating alternatives to animal testing
Advocate for faster regulatory validation pathways for non-animal testing methods
Choose products certified by cruelty-free schemes that support alternative method development
Donate to research institutions developing organ-on-chip, organoid and computer modeling alternatives